Want to join the conversation?
$CNIF 2Q15 Call: Overall pricing for the second quarter was very similar to the first quarter with average renewal price increases per commercialize continuing the percentages near the middle of the low-single digit range. That average includes the meeting affect of 3-year policies that were not yet subject to renewal during the second quarter.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.